Search Results 261-270 of 11344 for Pneumocystis pneumonia

  1. ... pneumococcal 13-val conj vaccine-dip crm (PF) 0.5 mL IM syringe,281.39 55 ... pneumococcal 23 polyvalent vaccine 25 mcg/0.5 mL injection solution ...

  2. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

    ... pneumonia, or pyelonephritis) within 6 months prior to screening; Has or has ... Pneumocystis carinii, aspergillosis, histoplasmosis, or mycobacteria ...

  3. Respiratory - Mayo Clinic Healthcare

    Pneumonia and chest infections. Pneumothorax. Primary lung tumours. Pulmonary embolism (lung blood clots). Pulmonary fibrosis. Sarcoidosis. Sleep apnoea.

  4. Primary immunodeficiency - Symptoms and causes - Mayo Clinic

    Getting infections often, including pneumonia, bronchitis, sinus infections, ear infections, meningitis or skin infections. Inflammation and infection of ...

  5. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

  6. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  7. Publications - Ali Duarte-Garcia, M.D. - Mayo Clinic

    2025 Feb 26; 70(4):492-495. Epub 2024 Dec 21. View PubMed; Jiang Y, Duarte-Garcia AA, Putman MS, Gazeley DJ. Incidence of Pneumocystis jirovecii Pneumonia and ...

  8. A Study To Evaluate GB002 In Adults With Pulmonary Arterial Hypertension (PAH) - Mayo Clinic

    A positive test for drugs of abuse (amphetamines, methamphetamines, cocaine, phencyclidine [PCP]). NOTE: Additional inclusion/exclusion criteria may apply ...

  9. ... pneumococcal 13-val conj vaccine-dip crm (PF) 0.5 mL IM syringe,281.39 ... pneumococcal 23 polyvalent vaccine 25 mcg/0.5 mL injection solution ...

  10. Phase II Venetoclax, Obinutuzumab And Bendamustine In High Tumor Burden Follicular Lymphoma As Front Line Therapy - Mayo Clinic

    Must be willing to take prophylaxis for Pneumocystis jiroveci pneumonia during therapy and until at least 2 months following the completion of therapy or ...